Thuja capital portfolio company ArGEN-X raises EUR 9.5M
The deal was co-led by Forbion Capital Partners and Life Sciences Partners (LSP). Christina Takke for Forbion Capital Partners and John de Koning for LSP have joined the arGEN-X Supervisory Board. Other members of the syndicate are KBC Private Equity (Belgium), BioGeneration Ventures (The Netherlands) and existing shareholders Erasmus MC Biomedical Fund and Thuja Capital Healthcare Funds.
ArGEN-X was seed funded in April 2008 by Thuja Capital Healthcare Seed Fund in collaboration with Erasmus MC Biomedical Fund.
Most read news
Other news from the department business & finance
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.